Poorer survival of male breast cancer compared with female breast cancer patients may be due to biological differences

Japanese Journal of Clinical Oncology

Volumn 43, Issue 10, 2013, Pages 954-963

  Chen, Xingyu ^a   Liu, Xiaodong ^a   Zhang, Li ^a   Li, Shufen ^a   Shi, Yehui ^a   Tong, Zhongsheng ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Female breast cancer; Male breast cancer; Prognosis

Indexed keywords

HORMONE; HORMONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; COMPARATIVE STUDY; DATA BASE; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; SEX DIFFERENCE; SURVIVAL RATE; TUMOR LOCALIZATION; TUMOR VOLUME;

FEMALE BREAST CANCER; MALE BREAST CANCER; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; CASE-CONTROL STUDIES; CHEMOTHERAPY, ADJUVANT; CHINA; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MASTECTOMY; MEDICAL RECORDS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 84885134307     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyt116     Document Type: Article

References (40)

1. AndersonWF, Jatoi I, Tse J, et al. Male breast cancer: a population-based comparison with female breast cancer. J Clin Oncol 2010;28:232-9.
2. Contractor KB, Kaur K, Rodrigues GS, Kulkarni DM, Singhal H. Male breast cancer: is the scenario changing. World J Surg Oncol 2008;6:58.
3. Speirs V, Shaaban AM. The rising incidence of male breast cancer. Breast Cancer Res Treat 2009;115:429-30.
4. Malani AK. Male breast cancer: a different disease than female breast cancer?. South Med J 2007;100:197.
5. Wang-Rodriguez J, Cross K, Gallagher S, et al. Male breast carcinoma: correlation of ER, PR, Ki-67, Her2Neu, and p53 with treatment and survival, a study of 65 cases. Mod Pathol 2002;15:853-61.
6. Ciatto S, Iossa A, Bonardi R, Pacini P. Male breast carcinoma: review of a multicenter series of 150 cases. Coordinating Center and Writing Committee of FONCAM (National Task Force for Breast Cancer), Italy. Tumori 1990;76:555-8.
7. Salvadori B, Saccozzi R, Manzari A, et al. Prognosis of breast cancer in males: an analysis of 170 cases. Eur J Cancer 1994;30A930-5.
8. Donegan WL, Redlich PN, Lang PJ, Gall MT. Carcinoma of the breast in males: a multiinstitutional survey. Cancer 1998;83:498-509.
9. Yildirim E, Berberoglu U. Male breast cancer: a 22-year experience. Eur J Surg Oncol 1998;24:548-52.
10. Tajima N, Tsukuma H, Oshima A. Descriptive epidemiology of male breast cancer in Osaka, Japan. J Epidemiol 2001;11:1-7.
11. Sandler B, Carmen C, Perry RR. Cancer of the male breast. Am Surg 1994;60:816-20.
12. Fentiman IS, Fourquet A, Hortobagyi GN. Male breast cancer. Lancet 2006;367:595-604.
13. Marchal F, Salou M, Marchal C, et al. Men with breast cancer have same disease-specific and event-free survival as women. Ann Surg Oncol 2009;16:972-8.
14. Lynn K. Rare male breast cancer has similarities to female disease. MLO Med Lab Obs 2010;42:34-6.
15. Feifei Z, Rong H, Jun J, et al. A meta-analysis based on case-control studies shows the similar prognosis between male and female patients with breast cancer. Chinese-German J Clin Oncol 2011;10:311-6.
16. El-Tamer MB, Komenaka IK, Troxel A, et al. Men with breast cancer have better disease-specific survival than women. Arch Surg 2004;139:1079-82.
17. Neumayer L, Schifftner TL, Henderson WG, et al. Breast cancer surgery in veterans affairs and selected university medical centers: results of the patient safety in surgery study. J Am Coll Surg 2007;204:1235-41.
18. Perou CM, Sørlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature 2000;406:747e52.
19. Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 2006;295:2492e502.
20. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. JASA 1958;53:457-81.
21. Zhou FF, Xia LP, Guo GF, et al. Changes in therapeutic strategies in Chinese male patients with breast cancer: 40 years of experience in a single institute. Breast 2010;19:450-55.
22. Giordano SH, Cohen DS, Buzdar AU, Perkins G, Hortobagyi GN. Breast carcinoma in men: a population-based study. Cancer 2004;101:51-7.
23. Thalib L, Hall P. Survival of male breast cancer patients: population-based cohort study. Cancer Sci 2009;100:292-5.
24. Hill TD, Khamis HJ, Tyczynski JE, Berkel HJ. Comparison of male and female breast cancer incidence trends, tumor characteristics, and survival. Ann Epidemiol 2005;15:773-80.
25. Gnerlich JL, Deshpande AD, Jeffe DB, et al. Poorer survival outcomes for male breast cancer compared with female breast cancer may be attributable to in-stage migration. Ann Surg Oncol 2011;18:1837-44.
26. Agrawal A, Ayantunde AA, Rampaul R, Robertson JF. Male breast cancer: a review of clinical management. Breast Cancer Res Treat 2007;103:11-21.
27. Kornegoor R, Verschuur-Maes AH, Buerger H, et al. Molecular subtyping of male breast cancer by immunohistochemistry. Mod Pathol 2012;25:398-404.
28. Ge Y, Sneige N, Eltorky MA, et al. Immunohistochemical characterization of subtypes of male breast carcinoma. Breast Cancer Res 2009;11:R28.
29. Tiezzi DG, Andrade JM, Ribeiro-Silva A, et al. HER2, p53, p21 and hormonal receptors proteins expression as predictive factors of response and prognosis in locally advanced breast cancer treated with neoadjuvant docetaxel plus epirubicin combination. BMC Cancer 2007;7:36.
30. Yu X-F, Feng W-L, Miao L-L, Chen B, Yang H-J. The prognostic significance of molecular subtype for male breast cancer: a 10-year retrospective study. Breast 2013;14:36-2.
31. Giordano SH, Buzdar AU, Hortobagyi GN. Breast cancer in men. Ann Intern Med 2002;137:678-87.
32. Joshi MG, Lee AK, Loda M, et al. Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome. Cancer 1996;77:490-8.
33. Ribeiro GG, Swindell R, Harris M, Banerjee SS, Cramer A. A review of the management of the male breast carcinoma based on an analysis of 420 treated cases. Breast 1996;5:141-6.
34. Giordano SH, Perkins GH, Broglio K, et al. Adjuvant systemic therapy for male breast carcinoma. Cancer 2005;104:2359-64.
35. Eggemann H, Ignatov A, Smith BJ, et al. Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients. Breast Cancer Res Treat 2013;137:465-70.
36. Giordano SH. A review of the diagnosis and management of male breast cancer. Oncologist 2005;10:471-9.
37. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin 2004;54:8-29.
38. Pich A, Margaria E, Chiusa L, et al. Androgen receptor expression in male breast carcinoma: lack of clinicopathological association. Br J Cancer 1999;79:959-64.
39. Nahleh ZA. Hormonal therapy for male breast cancer: a different approach for a different disease. Cancer Treat Rev 2006;32:101-5.
40. Müller AC, Gani C, Rehm HME, et al. Are there biologic differences between male and female breast cancer explaining inferior outcome of men despite equal stage and treatment?. Strahlenther Onkol 2012;188:782-7.